Wyndly is a seed startup based in United States. 2 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Wyndly is a telehealth company providing personalized allergy treatment plans, including at-home testing and sublingual immunotherapy, to help patients achieve long-term relief from allergies.
Stage
seed
Investors
2
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky